RETRACTED: An open-label trial comparing alendronate and alphacalcidol in reducing falls and hip fractures in disabled stroke patients
- PMID: 20598577
- DOI: 10.1016/j.jstrokecerebrovasdis.2009.10.007
RETRACTED: An open-label trial comparing alendronate and alphacalcidol in reducing falls and hip fractures in disabled stroke patients
Retraction in
-
Retraction notice to "An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients" [Journal of Stroke and Cerebrovascular Diseases, Volume 20, Issue 1, January-February 2011, Pages 41-46].J Stroke Cerebrovasc Dis. 2019 Nov;28(11):104426. doi: 10.1016/j.jstrokecerebrovasdis.2019.104426. J Stroke Cerebrovasc Dis. 2019. PMID: 31668218 No abstract available.
Abstract
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief due to include issues around study governance (ethical oversight and funding), implausible participant recruitment, implausible study conduct and publication timelines, authorship misconduct, conflicting statements about randomization methodology, implausibly similar randomized groups, implausible results, impossible results, duplicate reporting and data errors. In addition, several other publications reporting non-randomized research by members of this group of investigators have been retracted.
Copyright © 2011 National Stroke Association. Published by Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
